XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Equity-Based Compensation  
Summary of the restricted stock

​

​

​

​

​

​

​

​

​

​

​

WEIGHTED-

​

​

​

​

AVERAGE

​

​

​

​

GRANT DATE

​

    

SHARES

    

FAIR VALUE

Non-vested restricted stock as of December 31, 2021

​

3,910,722

​

$

23.18

Granted

​

66,220

​

​

17.07

Vested

​

(1,772,239)

​

 

22.87

Forfeited

​

(229,854)

​

 

23.00

Cancelled

​

(66,220)

​

​

23.00

Non-vested restricted stock as of September 30, 2022

​

1,908,629

​

$

23.28

Summary of the Company's RSU activity

​

​

​

​

​

​

​

​

​

​

​

WEIGHTED-

​

​

​

​

AVERAGE 

​

​

​

​

GRANT DATE 

​

    

UNITS

    

FAIR VALUE

Non-vested RSUs as of December 31, 2021

 

1,288,724

​

$

29.28

Granted*

 

1,415,901

​

 

22.10

Vested**

 

(420,168)

​

 

28.52

Forfeited

 

(149,610)

​

 

24.87

Non-vested RSUs as of September 30, 2022

 

2,134,847

​

$

24.98

Schedule of nonvested Performance-based Units activity

​

​

​

​

​

​

​

​

​

​

​

WEIGHTED-

​

​

​

​

AVERAGE 

​

​

​

​

GRANT DATE 

​

    

UNITS

    

FAIR VALUE

Non-vested PSUs as of December 31, 2021

 

406,575

​

$

27.35

Granted

 

361,147

​

 

22.25

Vested

 

(12,291)

​

 

24.83

Forfeited

 

(57,077)

​

 

35.47

Non-vested PSUs as of September 30, 2022

 

698,354

​

$

24.10

Schedule of compensation expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

THREE MONTHS ENDED SEPTEMBER 30, 

​

NINE MONTHS ENDED SEPTEMBER 30, 

​

​

2022

    

2021

    

2022

    

2021

Cost of revenues

​

$

2,454

​

$

1,442

​

$

6,834

​

$

3,738

Sales and marketing

​

 

160

​

 

602

​

 

1,670

​

 

1,636

Research and development

​

 

957

​

 

514

​

 

4,115

​

 

1,528

General and administrative

​

 

3,233

​

 

5,607

​

 

11,199

​

 

13,944

Total

​

$

6,804

​

$

8,165

​

$

23,818

​

$

20,846